SCHEMBL3148316

SCHEMBL3148316

COC(=O)c1ccc2c(c1)NC(=O)C2=C(Nc1ccc(N(CCN)S(C)(=O)=O)cc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.41
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPT P10636 1/20 0.38
KMT2A Q03164 6/20 0.37
L3MBTL1 Q9Y468 4/20 0.37
MEN1 O00255 4/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 2/20 0.37
TSHR P16473 2/20 0.37
HSD17B10 Q99714 1/20 0.37
CASP1 P29466 1/20 0.36
SENP1 Q9P0U3 1/20 0.35
THRB P10828 2/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
BACE1 P56817 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3148305 1.00 POLB (0.41) POLBRAB9ANPC1SMN1; SMN2MAPT
SCHEMBL479283 0.93 RXFP1 (0.42) RAB9ANPC1SMN1; SMN2MAPTKMT2A
SCHEMBL2569908 0.93 RXFP1 (0.42) RAB9ANPC1SMN1; SMN2MAPTKMT2A
SCHEMBL2566882 0.92 POLB (0.41) POLBRAB9ANPC1SMN1; SMN2MAPT
SCHEMBL2566884 0.92 POLB (0.41) POLBRAB9ANPC1SMN1; SMN2MAPT
SCHEMBL5313218 0.92 POLB (0.41) POLBRAB9ANPC1SMN1; SMN2MAPT
SCHEMBL30737901 0.92 POLB (0.41) POLBRAB9ANPC1SMN1; SMN2MAPT
SCHEMBL3150809 0.91 POLB (0.41) POLBRAB9ANPC1SMN1; SMN2MAPT
SCHEMBL3150802 0.91 POLB (0.41) POLBRAB9ANPC1SMN1; SMN2MAPT
SCHEMBL2121902 0.90 POLB (0.40) POLBRAB9ANPC1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157081-A1 Indolinones substituted in six locations, their manufacture and their application as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2010-02-24 EP disclosed
EP-1224170-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT Boehringer Ingelheim Pharma KG (DE) 2002-07-24 EP disclosed
WO-2001027081-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-04-19 WO disclosed